Carlsmed Appoints Tony Jarc as Chief Product and AI Officer
Key Highlights
- ➤Tony Jarc appointed Chief Product and AI Officer at Carlsmed (CARL), effective immediately
- ➤Jarc will lead next-generation technology, surgical UI/UX, and personalized spine surgery commercialization
- ➤Enhanced CMS reimbursement for all aprevo® lumbar fusion procedures effective today
- ➤Tony Jarc joins Carlsmed (CARL) from Intuitive Surgical after more than 15 years
Expert Statements
Mike Cordonnier, Chairman and CEO of Carlsmed
“Tony’s addition comes at a pivotal moment as we transform our technology platform to scale and advance our patient-centric innovation for our highly differentiated personalized surgery business”
Mike Cordonnier, Chairman and CEO of Carlsmed
“As a true thought leader in the clinical deployment of AI-enabled surgical technologies at a large scale, I am thrilled to have Tony join our team and further elevate our market leadership position.”
Tony Jarc, Chief Product and AI Officer of Carlsmed
“I am excited to join a Carlsmed team that has truly advanced spine surgery through its commitment to clinical research and deployment of technology, and generated meaningful evidence to support that these solutions improve patient outcomes”
Tony Jarc, Chief Product and AI Officer of Carlsmed
“There is incredible opportunity to build on this foundation, both in the development of new products and the enhancement of our existing solutions. I look forward to working with Mike and the team to execute this vision.”
CARLSBAD, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that Tony Jarc, Ph.D. has been appointed to the newly-created position of Chief Product and AI Officer, effective immediately. Dr. Jarc will lead the development and commercialization of the Company’s next generation technology platform, surgical UI/UX, and personalized spine surgery procedures.
“Tony’s addition comes at a pivotal moment as we transform our technology platform to scale and advance our patient-centric innovation for our highly differentiated personalized surgery business," said Mike Cordonnier, Chairman and CEO. "As a true thought leader in the clinical deployment of AI-enabled surgical technologies at a large scale, I am thrilled to have Tony join our team and further elevate our market leadership position.”
Get started
Create a free account to read the full story.